Olivier Trédan

24PUBLICATIONS
190CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCross-sectional analysisExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 11, 2026
Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer.

|Apr 06, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.

Komal Jhaveri, Lisa D Eli, Sara A Hurvitz

|Jan 08, 2026
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.

Félix Blanc-Durand, Catherine Genestie, Sergey Nikolaev

|Dec 30, 2025
Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles.

Simon Aho, Clio Coste, Luiza Purcari

|Sep 10, 2025
Reply to: Critical evaluation of the ProfiLER-02 study design and outcomes.

Olivier Trédan, Marie-Sarah Cabrillac, Sylvie Chabaud

|Apr 08, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial.

Olivier Trédan, Damien Pouessel, Nicolas Penel

Pageof 4

Frequent Collaborators

7 joint publications

Thomas Bachelot

5 joint publications

Armelle Dufresne

5 joint publications

Barbara Pistilli

4 joint publications

Ines Vaz-Luis